US trade chief defends tariffs as Democrats say Trump ‘in denial’ over price hikes
ONP Summary
Trump announced a phased tariff plan on imported generic drugs with 0% duties for two years starting August 1, 2026, escalating to 100% by August 2028. Concurrently, he plans tariffs of 10–12.5% on 60+ trading partners to replace an expiring 10% global levy, citing alleged forced labor violations.
Progressive:Protectionist unilateralism — Progressive outlets emphasize Trump's unilateral tariff decisions and their impact on established suppliers like India.
Moderate:Labor-focused tariff shift — Moderate outlets present the tariffs as restructuring trade rules in response to alleged forced labor violations.
Conservative:Domestic production incentive — Conservative outlets highlight the tariffs as strategy to restore pharmaceutical manufacturing within the US.
Jamieson Greer denies tariffs have pushed up prices during grilling from lawmakers over cost-of-living concerns
Donald Trump’s chief trade official denied the president’s sweeping tariffs have increased prices for US families, as lawmakers challenged him over cost-of-living concerns across much of the country.
US inflation surged to a three-year high earlier this year. During a heated exchange before US senators on Wednesday, however, US trade representative Jamieson Greer appeared to claim Trump’s controversial economic agenda had not driven prices higher.
Continue reading...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요